Celldex Therapeutics buy Stifel Nicolaus
Start price
26.02.26
/
50%
€26.00
Target price
26.02.27
€57.53
Performance (%)
-1.54%
Price
27.02.26
€25.60
Summary
This prediction is currently active. With a performance of -1.54%, the BUY prediction for Celldex Therapeutics by Stifel_Nicolaus is down slightly. This prediction currently runs until 26.02.27. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | -1.54% |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | -0.411% |
| iShares Nikkei 225® | 1.838% |
| iShares S&P 500 | -0.712% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€33.20
18.06.24
18.06.24
€54.03
18.06.25
18.06.25
-45.18%
19.06.25
19.06.25
